Capillary Technologies India (CAPILLARY) Q4 24/25 earnings summary

Executive summary

• Consolidated revenue rose to ₹5,982.59 million in FY 2024-25 from ₹4,833.97 million in FY 2023-24, with net profit at ₹132.75 million versus a net loss of ₹593.76 million last year.

• Standalone revenue increased to ₹1,740.91 million from ₹1,186.21 million, with net profit of ₹35.06 million compared to a net loss of ₹523.34 million in the prior year.

• No dividend declared and no transfer to reserves for FY 2024-25.

Financial highlights

• EBITDA for the consolidated entity was ₹785.73 million, up from negative EBITDA last year.

• EPS (consolidated) improved to ₹1.81 from a loss per share of ₹(10.55) year-over-year.

• Cash and cash equivalents at year-end were ₹2,140.71 million (consolidated).

• Significant reduction in borrowings and improved debt-equity ratio.

Outlook and guidance

• Management expects continued growth in operations and improved cash flows, supporting long-term sustainability.

• No material changes or commitments affecting financial position post year-end.